Founded in the UK in 2002, Pharmidex provides translational solutions in state-of-the-art facilities in London and Hatfield offering high-quality bespoke experimental data to support drug discovery and development.
We have comprehensive in-house laboratory facilities as well as extensive in vitro and in vivo assay options.
This enables us to provide tailored studies designed to meet individual project needs. Through extensive knowledge of drug discovery and development, Pharmidex has been able to deliver a high level of customer satisfaction and forge several strategic international alliances, focusing on operations in the following areas:
In vitro ADMET
In vivo pharmacology
CNS drug discovery
Bioanalysis and metabolite Identification
BioAnalysis and Metabolism
Our bioanalysis service is focused on enabling our clients to make good decisions on progression of compounds towards candidate selection and beyond in a timely and high-quality manner.
CerenseSM Drug Delivery System
CerenseSM is a product development platform, offered in collaboration with Genzyme Pharmaceuticals, designed to substantially improve the development success of CNS medicines that normally exhibit poor permeation of the blood brain barrier (BBB).
Pharmidex can provide PK, PD, target engagement and efficacy information for novel therapeutic agents in development.
Pharmidex is a contract research organisation providing unique solutions to support central nervous system (CNS) drug discovery and development. We are world leaders in the assessment of brain penetrability, target engagement and efficacy of CNS therapeutic agents.
don't forget to mention that you found this ad on Expert Web World Directory Website.
Pharmidex Pharmaceutical Services LTD
Contact Number: +44 (0) 870 240 5978
If number is not correct inform us.
Address: Office 3.05, Atlas House, 1 King Street, London
Please login to your member account to post reviews.